Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through the Drug Resource Enhancement Against AIDS and Malnutrition model: antiretrovirals for 5 reduction of population infectivity, incidence and prevalence at the district level.

Palombi L, Bernava GM, Nucita A, Giglio P, Liotta G, Nielsen-Saines K, Orlando S, Mancinelli S, Buonomo E, Scarcella P, Altan AM, Guidotti G, Ceffa S, Haswell J, Zimba I, Magid NA, Marazzi MC.

Clin Infect Dis. 2012 Jul;55(2):268-75. doi: 10.1093/cid/cis380. Epub 2012 Apr 5.

PMID:
22491503
[PubMed - indexed for MEDLINE]
Free Article
2.

Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.

Palombi L, Marazzi MC, Voetberg A, Magid NA.

AIDS. 2007 Jul;21 Suppl 4:S65-71.

PMID:
17620755
[PubMed - indexed for MEDLINE]
3.

Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.

Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, Germano P, Majid NA, Zimba I, Ceffa S, Palombi L.

Pediatr Infect Dis J. 2009 Jun;28(6):483-7. doi: 10.1097/INF.0b013e3181950c56.

PMID:
19483516
[PubMed - indexed for MEDLINE]
4.

Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.

May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne JA, Dabis F, Egger M; IeDEA Southern Africa and West Africa.

Lancet. 2010 Aug 7;376(9739):449-57. doi: 10.1016/S0140-6736(10)60666-6. Epub 2010 Jul 15.

PMID:
20638120
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The impact of HIV-1 infection on mortality in children under 5 years of age in sub-Saharan Africa: a demographic and epidemiologic analysis.

Nicoll A, Timaeus I, Kigadye RM, Walraven G, Killewo J.

AIDS. 1994 Jul;8(7):995-1005.

PMID:
7946112
[PubMed - indexed for MEDLINE]
6.

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG.

Lancet. 2009 Jan 3;373(9657):48-57. doi: 10.1016/S0140-6736(08)61697-9. Epub 2008 Nov 27.

PMID:
19038438
[PubMed - indexed for MEDLINE]
7.

Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi.

Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Kumwenda NI, Miotti PG.

AIDS. 1998 Jan 22;12(2):197-203.

PMID:
9468369
[PubMed - indexed for MEDLINE]
8.

Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation.

Cambiano V, Bertagnolio S, Jordan MR, Pillay D, Perriëns JH, Venter F, Lundgren J, Phillips A.

AIDS. 2014 Jan;28 Suppl 1:S15-23. doi: 10.1097/QAD.0000000000000082.

PMID:
24468943
[PubMed - indexed for MEDLINE]
9.

Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.

Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Zimba I, Magid NA, Buonomo E, Scarcella P, Ceffa S, Paturzo G, Narciso P, Liotta G.

AIDS. 2011 Aug 24;25(13):1611-8. doi: 10.1097/QAD.0b013e3283493ed0.

PMID:
21673553
[PubMed - indexed for MEDLINE]
10.

Modelling the impact of antiretroviral use in resource-poor settings.

Baggaley RF, Garnett GP, Ferguson NM.

PLoS Med. 2006 Apr;3(4):e124. Epub 2006 Mar 14.

PMID:
16519553
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.

Duncombe C, Kerr SJ, Ruxrungtham K, Dore GJ, Law MG, Emery S, Lange JM, Phanuphak P, Cooper DA.

AIDS. 2005 Jan 28;19(2):169-78.

PMID:
15668542
[PubMed - indexed for MEDLINE]
12.

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.

Staehelin C, Rickenbach M, Low N, Egger M, Ledergerber B, Hirschel B, D'Acremont V, Battegay M, Wagels T, Bernasconi E, Kopp C, Furrer H; Swiss HIV Cohort Study.

AIDS. 2003 Oct 17;17(15):2237-44.

PMID:
14523281
[PubMed - indexed for MEDLINE]
13.

Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.

Rowley JT, Anderson RM, Ng TW.

AIDS. 1990 Jan;4(1):47-56.

PMID:
2317308
[PubMed - indexed for MEDLINE]
14.

Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.

Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R; APROCO COPILOTE ANRS CO8 Study Group.

HIV Med. 2007 Apr;8(3):164-70.

PMID:
17461860
[PubMed - indexed for MEDLINE]
15.

Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.

De Beaudrap P, Boullé C, Lewden C, Gabillard D, Nacro B, Diagbouga S, Fassinou P, Hien H, Laurent C, Msellati P; ANRS 12222 Morbidity/Mortality Study Group.

Pediatr Infect Dis J. 2013 Apr;32(4):354-60. doi: 10.1097/INF.0b013e318278b222.

PMID:
23099424
[PubMed - indexed for MEDLINE]
16.

Effect of variable transmission rate on the dynamics of HIV in sub-Saharan Africa.

Cuadros DF, Crowley PH, Augustine B, Stewart SL, García-Ramos G.

BMC Infect Dis. 2011 Aug 11;11:216. doi: 10.1186/1471-2334-11-216.

PMID:
21834977
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals.

Lohse N, Obel N, Kronborg G, Laursen A, Pedersen C, Larsen CS, Kvinesdal B, Sørensen HT, Gerstoft J.

AIDS. 2005 May 20;19(8):815-22.

PMID:
15867496
[PubMed - indexed for MEDLINE]
18.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
[PubMed - indexed for MEDLINE]
19.

Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi.

Luebbert J, Tweya H, Phiri S, Chaweza T, Mwafilaso J, Hosseinipour MC, Ramroth H, Schnitzler P, Neuhann F.

Clin Infect Dis. 2012 Aug;55(3):441-8. doi: 10.1093/cid/cis438. Epub 2012 May 9.

PMID:
22573849
[PubMed - indexed for MEDLINE]
Free Article
20.

Usefulness of an observational database to assess antiretroviral treatment trends in India.

Cecelia AJ, Christybai P, Anand S, Jayakumar K, Gurunathan T, Vidya P, Solomon S, Kumarasamy N.

Natl Med J India. 2006 Jan-Feb;19(1):14-7.

PMID:
16570679
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk